Results 31 to 40 of about 825 (86)

Stroke：0.6 mg/kg阿替普酶更适合发病时间不明的缺血性卒中患者？

Zhongguo cuzhong zazhi, 2020
杨中华
doaj   +1 more source

阿替普酶静脉溶栓后双重抗血小板治疗内囊预警综合征1例并文献复习

Zhongguo cuzhong zazhi, 2020
王丽娟，刘欣，王红霞，吕娜，刘荧，李小刚
doaj   +1 more source

替罗非班联合阿替普酶治疗后循环梗死1例报告及文献复习

Zhongguo cuzhong zazhi, 2019
尹顺雄，唐妍妍，何素珍，言雷，刘贤俊，唐荣，吴辉丽
doaj   +1 more source

1例脑梗死静脉溶栓病例的思考 A Case Retreat of Intravenous Thrombolysis in Cerebral Infarction

Zhongguo cuzhong zazhi, 2018
卢桃利，张蓓
doaj   +1 more source

丁苯酞联合阿替普酶治疗缺血性卒中临床疗效的观察性研究

Zhongguo cuzhong zazhi, 2019
侯园园，梁志刚，孙旭文，杨绍婉，李冰，胡银宝
doaj   +1 more source

[Comparison of functional outcomes between tenecteplase and alteplase as bridging thrombolysis prior to mechanical throm-bectomy for acute ischemic stroke patients with large vessel occlusion]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Shi Z, Yang J, Lu Z, Cai Y, Zhu Y, Huang G, Zhu H, Lou M, Cheng J.   +8 more
europepmc   +1 more source

[Efficacy of intravenous thrombolysis beyond 4.5 to 24 hours in patients with isolated posterior circulation acute ischemic stroke]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Wang J, Yan S, Lang Y, Jin T, Tang H, Qian S, Yu H, Lou M, Chen H.   +8 more
europepmc   +1 more source

[Efficacy and safety of intravenous thrombolysis in patients with mild acute ischemic stroke]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Li X, Zhang X, Wang A, Wang T, Yan Y, Fu J, Zheng J, Lou M, Hu J.   +8 more
europepmc   +1 more source

[Chinese expert consensus on the diagnosis and management of nodal peripheral T-cell lymphoma (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Lymphoma Expert Committee of Chinese Society of Clinical Oncology (CSCO), Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association.   +3 more
europepmc   +1 more source

[Advances in targeted therapies for chronic spontaneous urticaria]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Zhou L, Hu C, Wang S, Zhang R.
europepmc   +1 more source